Loading company…
Nabsys develops electronic genome mapping tools for research and clinical laboratories.
Nabsys develops electronic genome mapping technology for genomic analysis, including the OhmX Analyzer for detecting structural variants and Human Chromosome Explorer software for genome assembly and variant identification. Its products serve academic and clinical laboratories. Founded in 2004 and based in Providence, US, the company raised USD 13.00 mn in a Series B round in August 2024, led by Hitachi High-Tech Corporation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in